These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 20378242)

  • 1. Genetics of patent foramen ovale--NKX2-5 and beyond.
    Elliott GC; Sargurupremraj M; Velupandian U; Gurtu R; Trump D; Newman W; Wang T; McCollum C
    Clin Neurol Neurosurg; 2010 Jul; 112(6):457-8. PubMed ID: 20378242
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutations in the NKX2-5 gene in patients with stroke and patent foramen ovale.
    Belvís R; Tizzano EF; Martí-Fàbregas J; Leta RG; Baena M; Carreras F; Pons-Lladó G; Baiget M; Martí-Vilalta JL
    Clin Neurol Neurosurg; 2009 Sep; 111(7):574-8. PubMed ID: 19464101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel stop mutation truncating critical regions of the cardiac transcription factor NKX2-5 in a large family with autosomal-dominant inherited congenital heart disease.
    Pabst S; Wollnik B; Rohmann E; Hintz Y; Glänzer K; Vetter H; Nickenig G; Grohé C
    Clin Res Cardiol; 2008 Jan; 97(1):39-42. PubMed ID: 17891520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum of atrial septal defects associated with mutations of NKX2.5 and GATA4 transcription factors.
    Sarkozy A; Conti E; Neri C; D'Agostino R; Digilio MC; Esposito G; Toscano A; Marino B; Pizzuti A; Dallapiccola B
    J Med Genet; 2005 Feb; 42(2):e16. PubMed ID: 15689439
    [No Abstract]   [Full Text] [Related]  

  • 5. Novel NKX2-5 mutations in diseased heart tissues of patients with cardiac malformations.
    Reamon-Buettner SM; Hecker H; Spanel-Borowski K; Craatz S; Kuenzel E; Borlak J
    Am J Pathol; 2004 Jun; 164(6):2117-25. PubMed ID: 15161646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic mutations in cardiac malformations.
    Reamon-Buettner SM; Borlak J
    J Med Genet; 2006 Aug; 43(8):e45. PubMed ID: 16882739
    [No Abstract]   [Full Text] [Related]  

  • 7. A tyrosine-rich domain within homeodomain transcription factor Nkx2-5 is an essential element in the early cardiac transcriptional regulatory machinery.
    Elliott DA; Solloway MJ; Wise N; Biben C; Costa MW; Furtado MB; Lange M; Dunwoodie S; Harvey RP
    Development; 2006 Apr; 133(7):1311-22. PubMed ID: 16510504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease.
    Reamon-Buettner SM; Borlak J
    J Med Genet; 2004 Sep; 41(9):684-90. PubMed ID: 15342699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrioventricular conduction system and transcription factors Nkx2.5 and Msx2.
    Harris BS; Gourdie RG; O'Brien TX
    J Cardiovasc Electrophysiol; 2005 Jan; 16(1):86-7. PubMed ID: 15673395
    [No Abstract]   [Full Text] [Related]  

  • 10. [Preliminary exploration of transcription factor Nkx2.5 mutations and congenital heart diseases].
    Ding JD; Li KR; Zhang XL; Yao YY; Reng LQ; Tao SY; Fang X; Ma GS
    Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(16):1114-6. PubMed ID: 19595143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac transcription factor Csx/Nkx2-5: Its role in cardiac development and diseases.
    Akazawa H; Komuro I
    Pharmacol Ther; 2005 Aug; 107(2):252-68. PubMed ID: 15925411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart disease: an ongoing genetic battle?
    Srivastava D
    Nature; 2004 Jun; 429(6994):819-22. PubMed ID: 15215849
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular basis of AV block and cardiac malformations.
    Mittmann C
    Cardiovasc Res; 2004 Oct; 64(1):1-2. PubMed ID: 15364605
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel point mutation in the NKX2-5 gene in a Moroccan family with atrioventricular conduction disturbance and an atrial septal defect in the oval fossa.
    Rifai L; Maazouzi W; Sefiani A
    Cardiol Young; 2007 Feb; 17(1):107-9. PubMed ID: 17184575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NKX2.5 mutations in patients with non-syndromic congenital heart disease.
    Gioli-Pereira L; Pereira AC; Mesquita SM; Xavier-Neto J; Lopes AA; Krieger JE
    Int J Cardiol; 2010 Feb; 138(3):261-5. PubMed ID: 19073351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NKX2.5/NKX2.6 mutations are not a common cause of isolated type 1 truncus arteriosus in a small cohort of multiethnic cases.
    Khetyar M; Tinworth L; Syrris P; Abushaban L; Abdulazzaq Y; Silengo M; Carvalho J; Carter N
    Genet Test; 2008 Dec; 12(4):467-9. PubMed ID: 18939937
    [No Abstract]   [Full Text] [Related]  

  • 17. Function follows form: cardiac conduction system defects in Nkx2-5 mutation.
    Jay PY; Harris BS; Buerger A; Rozhitskaya O; Maguire CT; Barbosky LA; McCusty E; Berul CI; O'brien TX; Gourdie RG; Izumo S
    Anat Rec A Discov Mol Cell Evol Biol; 2004 Oct; 280(2):966-72. PubMed ID: 15368343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations of transcription factors in human with heart disease for understanding the development and mechanisms of congenital cardiovascular heart disease.
    Matsuoka R
    Adv Exp Med Biol; 2005; 565():349-57; discussion 405-15. PubMed ID: 16106988
    [No Abstract]   [Full Text] [Related]  

  • 19. [Progress in studies on somatic mutations in congenital heart disease].
    Yin J; Yang SW; Qin YM
    Zhonghua Er Ke Za Zhi; 2012 Aug; 50(8):634-5. PubMed ID: 23158746
    [No Abstract]   [Full Text] [Related]  

  • 20. Is closure recommended for patent foramen ovale and cryptogenic stroke? Patent foramen ovale in cryptogenic stroke: not to close.
    Messé SR; Kasner SE
    Circulation; 2008 Nov; 118(19):1999-2004. PubMed ID: 18981314
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.